Integrated Filing — IndAS



General information about company
Scrip Code 523642
NSE Symbol PIIND
MSEI Symbol NOTLISTED
ISIN INE603J01030
Name of company PI INDUSTRIES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Date of board meeting when results were approved 12-Aug-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 05-Aug-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 12-Aug-2025   14:00:00
End date and time of board meeting 12-Aug-2025   18:30:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 19005000000
Other income 859000000
Total income 19864000000
2 Expenses
(a) Cost of materials consumed 7574000000
(b) Purchases of stock-in-trade 338000000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 179000000
(d) Employee benefit expense 2323000000
(e) Finance costs 39000000
(f) Depreciation, depletion and amortisation expense 965000000
(f) Other Expenses
1 Net Impairment losses on Financial Assets 85000000 85000000
2 Power, Fuel & Water 725000000 725000000
3 Environment & Pollution Control Expenses 359000000 359000000
4 Freight & Cartage 147000000 147000000
5 Advertisement & Sales Promotion 168000000 168000000
6 Travelling and Conveyance 262000000 262000000
7 Legal & professional fees 386000000 386000000
8 Repairs & Maintenance 325000000 325000000
9 Laboratory & Testing Charges 128000000 128000000
10 Other Expenses 815000000 815000000
Total other expenses 3400000000
Total expenses 14818000000
3 Total profit before exceptional items and tax 5046000000
4 Exceptional items 0
5 Total profit before tax 5046000000
6 Tax expense
7 Current tax 918000000
8 Deferred tax 156000000
9 Total tax expenses 1074000000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
11 Net Profit Loss for the period from continuing operations 3972000000
12 Profit (loss) from discontinued operations before tax 0
13 Tax expense of discontinued operations 0
14 Net profit (loss) from discontinued operation after tax 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 28000000
16 Total profit (loss) for period 4000000000
17 Other comprehensive income net of taxes 433000000
18 Total Comprehensive Income for the period 4433000000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 4433000000
Total profit or loss, attributable to non-controlling interests 0
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 4433000000
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0
21 Details of equity share capital
Paid-up equity share capital 152000000
Face value of equity share capital 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 26.37
Diluted earnings (loss) per share from continuing operations 26.36
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0
Diluted earnings (loss) per share from discontinued operations 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 26.37
Diluted earnings (loss) per share from continuing and discontinued operations 26.36
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025
Date of end of reporting period 30-Jun-2025
Whether accounts are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Agro Chemicals 18287000000 18287000000
2 Pharma 723000000 723000000
3 Inter Segment Adjustment 0 0
Total Segment Revenue 19010000000
Less: Inter segment revenue 5000000 5000000
Revenue from operations 19005000000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Agro Chemicals 5656000000 5656000000
2 Pharma -760000000 -760000000
3 Inter Segment Adjustment 178000000 178000000
Total Profit before tax 5074000000
i. Finance cost 0 0
ii. Other Unallocable Expenditure net off Unallocable income 0 0
Profit before tax 5074000000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Agro Chemicals 113301000000 113301000000
2 Pharma 14333000000 14333000000
3 Inter Segment Adjustment 0 0
Total Segment Asset 127634000000 127634000000
Un-allocable Assets 0 0
Net Segment Asset 127634000000 127634000000
4 Segment Liabilities
Segment Liabilities
1 Agro Chemicals 17272000000 17272000000
2 Pharma 4359000000 4359000000
3 Inter Segment Adjustment 0 0
Total Segment Liabilities 21631000000 21631000000
Un-allocable Liabilities 0 0
Net Segment Liabilities 21631000000 21631000000
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements gain/(loss) on cash flow hedges 9000000 9000000
Total Amount of items that will not be reclassified to profit and loss 9000000
2 Income tax relating to items that will not be reclassified to profit or loss 2000000
3 Amount of items that will be reclassified to profit and loss
1 Effective portion of gain/(loss) on cashflow hedges 77000000 77000000
2 Exchange difference on translation of foreign operations 376000000 376000000
Total Amount of items that will be reclassified to profit and loss 453000000
4 Income tax relating to items that will be reclassified to profit or loss 27000000
5 Total Other comprehensive income 433000000